Categories: Hospitals

Apollo Hospitals Celebrates Life with Over 1500 Patients Who Have Undergone Successful Bone Marrow Transplants (BMT)

  • Recorded 1500 BMTs across the Apollo Hospitals Group of which 65% are pediatric cases
  • Apollo Hospitals urge people to donate bone marrow and save lives!

Mumbai, June 22, 2018: Apollo Hospitals, India’s first multispecialty chain of hospitals reached a new milestone with over 1500 successful Bone Marrow Transplant (BMT) procedures conducted on patients across the Apollo Hospitals Group. The 1500 patients treated at Apollo BMT units have come from all over India including Chennai, Mumbai, Delhi, Kozhikode, Gujarat, West Bengal as well as from foreign countries like Oman, Bangladesh, Sri Lanka, Tanzania, Dubai, UAE, and Mauritius. Apollo Hospitals, Chennai was the first hospital to conduct India’s first cord blood transplant and unrelated transplant, and the 1500 BMT landmark carried out successfully across the group hospitals endorses the success of these high end procedures for both children and adults with survival rates comparable to western centres. Bone marrow transplantation saves the lives of patients with blood cancer and serious blood disorders like thalassemia major, aplastic anemia and primary immune deficiency.

Commenting on this milestone, Dr. Prathap C Reddy, Executive Chairman, Apollo Hospitals Group said, “We are proud of the commitment and drive shown by our team in this life saving achievement. I am glad that our team has helped over 1500 patients from across India as well as abroad to celebrate life and win over life threatening conditions through a Bone Marrow Transplant. For us, this number is just one milestone on our journey of healing. Though we have come a long way from the first successful BMT at Apollo in 1995, there are many more patients who are in need of BMT. It is extremely important that people come forward for bone marrow donation and help save more lives.”

Sharing his thoughts, Dr. Ramesh Nimmagadda, Director, Medical Oncology, Apollo Cancer Centre said, “Our patients come to us with a sense of hope and it is with joy and a sense of fulfilment that we are celebrating over 1500 lives on this occasion. It is not just a milestone that our team has achieved here, but more than that it is an occasion to celebrate the courage, determination and spirit of the patients whose age ranges from 6 weeks to 68 years! Innovation, technology, teamwork and dedication at the hospital have enabled us to take the lead in BMT.”

Equipped with highly qualified BMT team, and stringent infection control norms which are critical for BMT patients, BMT treatment is available across the Apollo Hospitals chain at Chennai, New Delhi, Hyderabad, Ahmedabad and Kolkata. Apollo Hospitals was the first corporate hospital in India to perform the procedure in 1995. Today, the BMT procedure performed at Apollo for over 40 different conditions have resulted in over 1500 people celebrating life.

The Apollo Hospitals group now marks a milestone being the first corporate hospital in India to cross 1500 BMT procedures.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

10 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago